Neumora Therapeutics Shares Are Trading Lower After the Company Announced Its Phase 3 KOASTAL Study Did Not Demonstrate Statistically Significant Improvement on Its Primary Endpoint.
Neumora Therapeutics Shares Are Trading Lower After the Company Announced Its Phase 3 KOASTAL Study Did Not Demonstrate Statistically Significant Improvement on Its Primary Endpoint.
Neumora Therapeutics的股票在公司宣布其第三阶段KOASTAL研究未能在主要终点上显示统计学显著改善后，股价下跌。
Neumora Therapeutics Shares Are Trading Lower After the Company Announced Its Phase 3 KOASTAL Study Did Not Demonstrate Statistically Significant Improvement on Its Primary Endpoint.
Neumora Therapeutics的股票在公司宣布其第三阶段KOASTAL研究未能在主要终点上显示统计学显著改善后，股价下跌。
热门讨论
特朗普2.0时代开启，全球股市新风口在哪里？
▪️加密货币政策能否利好crypto？ ▪️关税政策能否利好中概等海外资产？ ▪️在特朗普政策下，有哪些投资机会值得关注？
標普500
01/13 20:53
离川普上台只有7天了～